Correlation Between Crispr Therapeutics and Agilent Technologies

Can any of the company-specific risk be diversified away by investing in both Crispr Therapeutics and Agilent Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Crispr Therapeutics and Agilent Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Crispr Therapeutics AG and Agilent Technologies, you can compare the effects of market volatilities on Crispr Therapeutics and Agilent Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Crispr Therapeutics with a short position of Agilent Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Crispr Therapeutics and Agilent Technologies.

Diversification Opportunities for Crispr Therapeutics and Agilent Technologies

0.49

Correlation Coefficient

Crispr Therapeutics  Agilent Technologies

Very weak diversification

The 3 months correlation between Crispr and Agilent is 0.49. Overlapping area represents the amount of risk that can be diversified away by holding Crispr Therapeutics AG and Agilent Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Agilent Technologies and Crispr Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Crispr Therapeutics AG are associated (or correlated) with Agilent Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Agilent Technologies has no effect on the direction of Crispr Therapeutics i.e., Crispr Therapeutics and Agilent Technologies go up and down completely randomly.

Pair Corralation between Crispr Therapeutics and Agilent Technologies

Given the investment horizon of 90 days Crispr Therapeutics AG is expected to generate 2.27 times more return on investment than Agilent Technologies. However, Crispr Therapeutics is 2.27 times more volatile than Agilent Technologies. It trades about 0.2 of its potential returns per unit of risk. Agilent Technologies is currently generating about 0.07 per unit of risk. If you would invest  3,631  in Crispr Therapeutics AG on May 15, 2025 and sell it today you would earn a total of  2,102  from holding Crispr Therapeutics AG or generate 57.89% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Crispr Therapeutics AG  vs.  Agilent Technologies

Crispr Therapeutics

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Crispr Therapeutics AG are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Crispr Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.

Agilent Technologies

Risk-Adjusted Performance

Mild

Compared to the overall equity markets, risk-adjusted returns on investments in Agilent Technologies are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Agilent Technologies may actually be approaching a critical reversion point that can send shares even higher in September 2025.

Pair Trading with Crispr Therapeutics and Agilent Technologies

The main advantage of trading using opposite Crispr Therapeutics and Agilent Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Crispr Therapeutics position performs unexpectedly, Agilent Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Agilent Technologies will offset losses from the drop in Agilent Technologies' long position.

The idea behind Crispr Therapeutics AG and Agilent Technologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.